Literature DB >> 23790682

Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice.

Juan Jose Ramos-Rodriguez1, Oscar Ortiz, Margarita Jimenez-Palomares, Kevin R Kay, Esther Berrocoso, Maria Isabel Murillo-Carretero, German Perdomo, Tara Spires-Jones, Irene Cozar-Castellano, Alfonso Maria Lechuga-Sancho, Monica Garcia-Alloza.   

Abstract

Although age remains the main risk factor to suffer Alzheimer's disease (AD) and vascular dementia (VD), type 2 diabetes (T2D) has turned up as a relevant risk factor for dementia. However, the ultimate underlying mechanisms for this association remain unclear. In the present study we analyzed central nervous system (CNS) morphological and functional consequences of long-term insulin resistance and T2D in db/db mice (leptin receptor KO mice). We also included C57Bl6 mice fed with high fat diet (HFD) and a third group of C57Bl6 streptozotocin (STZ) treated mice. Db/db mice exhibited pathological characteristics that mimic both AD and VD, including age dependent cognitive deterioration, brain atrophy, increased spontaneous hemorrhages and tau phosphorylation, affecting the cortex preferentially. A similar profile was observed in STZ-induced diabetic mice. Moreover metabolic parameters, such as body weight, glucose and insulin levels are good predictors of many of these alterations in db/db mice. In addition, in HFD-induced hyperinsulinemia in C57Bl6 mice, we only observed mild CNS alterations, suggesting that central nervous system dysfunction is associated with well established T2D. Altogether our results suggest that T2D may promote many of the pathological and behavioral alterations observed in dementia, supporting that interventions devoted to control glucose homeostasis could improve dementia progress and prognosis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Brain atrophy; Spontaneous hemorrhage; Tau phosphorylation; Type 2 diabetes; Vascular dementia

Mesh:

Substances:

Year:  2013        PMID: 23790682     DOI: 10.1016/j.psyneuen.2013.05.010

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  48 in total

Review 1.  Role of insulin resistance in Alzheimer's disease.

Authors:  Zhiyou Cai; Ming Xiao; Liying Chang; Liang-Jun Yan
Journal:  Metab Brain Dis       Date:  2014-11-16       Impact factor: 3.584

Review 2.  Cerebrovascular complications of diabetes: focus on cognitive dysfunction.

Authors:  Trevor Hardigan; Rebecca Ward; Adviye Ergul
Journal:  Clin Sci (Lond)       Date:  2016-10-01       Impact factor: 6.124

3.  Dementia-like pathology in type-2 diabetes: A novel microRNA mechanism.

Authors:  Anuradha Kalani; Pankaj Chaturvedi; Claudio Maldonado; Philip Bauer; Irving G Joshua; Suresh C Tyagi; Neetu Tyagi
Journal:  Mol Cell Neurosci       Date:  2017-02-20       Impact factor: 4.314

Review 4.  Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.

Authors:  Geert Jan Biessels; Florin Despa
Journal:  Nat Rev Endocrinol       Date:  2018-10       Impact factor: 43.330

Review 5.  Metabolic tinkering by the gut microbiome: Implications for brain development and function.

Authors:  Joel Selkrig; Peiyan Wong; Xiaodong Zhang; Sven Pettersson
Journal:  Gut Microbes       Date:  2014-03-31

6.  Cognitive Impairment and Brain and Peripheral Alterations in a Murine Model of Intraventricular Hemorrhage in the Preterm Newborn.

Authors:  Antonio Segado-Arenas; Carmen Infante-Garcia; Isabel Benavente-Fernandez; Daniel Sanchez-Sotano; Juan Jose Ramos-Rodriguez; Almudena Alonso-Ojembarrena; Simon Lubian-Lopez; Monica Garcia-Alloza
Journal:  Mol Neurobiol       Date:  2017-07-28       Impact factor: 5.590

7.  Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.

Authors:  Carmen Infante-Garcia; Juan Jose Ramos-Rodriguez; Carmen Hierro-Bujalance; Esperanza Ortegon; Eleanor Pickett; Rosemary Jackson; Fernando Hernandez-Pacho; Tara Spires-Jones; Monica Garcia-Alloza
Journal:  Mol Neurobiol       Date:  2017-12-09       Impact factor: 5.590

8.  Impairment of cognitive flexibility in type 2 diabetic db/db mice.

Authors:  Leonid M Yermakov; Ryan B Griggs; Domenica E Drouet; Chiho Sugimoto; Michael T Williams; Charles V Vorhees; Keiichiro Susuki
Journal:  Behav Brain Res       Date:  2019-05-26       Impact factor: 3.332

Review 9.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

10.  Genistein modulation of streptozotocin diabetes in male B6C3F1 mice can be induced by diet.

Authors:  Tai L Guo; Yunbiao Wang; Tao Xiong; Xiao Ling; Jianfeng Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-30       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.